Insight Molecular Diagnostics Inc.
IMDX
$4.01
$0.184.70%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 1.14M | 260.00K | 518.00K | 2.14M | 1.49M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.14M | 260.00K | 518.00K | 2.14M | 1.49M |
| Cost of Revenue | 643.00K | 121.00K | 168.00K | 806.00K | 869.00K |
| Gross Profit | 496.00K | 139.00K | 350.00K | 1.33M | 617.00K |
| SG&A Expenses | 4.62M | 3.93M | 4.11M | 4.32M | 3.76M |
| Depreciation & Amortization | 0.00 | -- | -- | 7.00K | 22.00K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 22.26M | 7.93M | 7.56M | 7.98M | 6.91M |
| Operating Income | -19.98M | -7.67M | -7.04M | -5.84M | -5.42M |
| Income Before Tax | -22.96M | -10.85M | -9.74M | -6.67M | -33.51M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -22.96M | -10.85M | -9.74M | -6.67M | -33.51M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -22.96M | -10.85M | -9.74M | -6.67M | -33.51M |
| EBIT | -19.98M | -7.67M | -7.04M | -5.84M | -5.42M |
| EBITDA | -18.86M | -7.09M | -6.48M | -5.35M | -4.86M |
| EPS Basic | -0.72 | -0.34 | -0.30 | -0.26 | -1.93 |
| Normalized Basic EPS | -0.37 | -0.15 | -0.14 | -0.14 | -0.19 |
| EPS Diluted | -1.43 | -0.34 | -0.30 | -0.26 | -1.93 |
| Normalized Diluted EPS | -0.37 | -0.15 | -0.14 | -0.14 | -0.19 |
| Average Basic Shares Outstanding | 32.08M | 32.03M | 32.02M | 25.69M | 17.38M |
| Average Diluted Shares Outstanding | 32.08M | 32.03M | 32.02M | 25.69M | 17.38M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |